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Electric- and Lightning-Induced
Cardiac Arrest Reversed by
Prompt Cardiopulmonary
Resuscitation
To the Editor.\p=m-\Intheir article enti-
tled "Prehospital Cardiopulmonary
Resuscitation: Is It Effective?" Cum-
mins and Eisenberg1 state: "Clinical
evidence provides strong support for
efforts to increase the percent of
persons in cardiac arrests who receive
early bystander CPR [cardiopulmo-
nary resuscitation]. These efforts do
no harm and clearly save lives." We
wish to report a subgroup of patients
in whom early bystander-initiated
CPR may be dramatically successful.
Cardiac arrest induced by lightning
or electricity is a unique injury
because all patients may survive if
CPR is promptly instituted. The
potential success rate in this sub-
group can be compared with success
rates for resuscitation attempts in
the hospital and in the community.
When CPR is commenced in the hos-
pital, a success rate of 56% has been
reported.2 Figures for resuscitation in
the community are more difficult to
interpret as reported by Cummins
and Eisenberg, who have reviewed
the results from nine centers over the
last decade.1 Because some patients
are left with a residual neurological
deficit, any evaluation of the success
of resuscitation must therefore take
into account the neurological outcome
as well as survival.3
Report of Cases.—We report three
patients with high-voltage electrical in¬
juries and one patient with a lightning
injury who were successfully resuscitated
after cardiac arrest. The first patient, a
10-year-old boy, was found apneic and
pulseless by his mother five to ten minutes
after he was hit by lightning. She com¬
menced CPR for eight minutes while
awaiting the arrival of trained personnel.
After admission to hospital, the patient
was ventilated and had frequent runs of
ventricular tachycardia. Levels of the MB
isoenzyme of creatine phosphokinase were
elevated and changes suggestive of an
acute inferior myocardial infarction devel¬
oped but later resolved. The patient recov¬
ered but had amnesia for the event and
experienced personality changes.
Two firemen who sustained injuries
from line voltages of 8,000 and 33,000 V,
respectively, were resuscitated by their
colleagues at the time of injury. One
patient required a forequarter disarticula¬
tion, although neither patient developed
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electrocardiographic abnormalities or ele¬
vated cardiac enzyme levels. Another
patient contacted a 7,000-V source at work
and was resuscitated by a bystander. Sub¬
sequent cardiac monitoring revealed no
abnormality and no change in enzyme
levels was detected. All three patients
recovered and have no symptoms referable
to the cardiovascular or neurological sys¬
tems on follow-up that ranges from three
to seven years.
Comment.—Optimally, CPR should
commence on cessation of the circula¬
tion. Because of the peculiar patho-
physiology of lightning injury, de¬
layed resuscitation may be effective.
It has been suggested that all cellular
metabolism ceases at the instant of
the strike, thereby slowing cellular
degeneration.4 Also, although the
pathophysiology may be different,
every effort should be made to resus¬
citate patients who are apparently
dead after electrical injury.
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Response to Deltoid Muscle
Injection of Hepatitis B Vaccine
After Failure to Respond to
Gluteal Injections
To the Editor.\p=m-\Werecently reported
a multivariate analysis of the risk
factors associated with a poor immu-
nogenic response to the hepatitis B
plasma vaccine among 194 employees
of a community hospital.1 The vaccine
had been stored and administered
according to manufacturer's recom-
mendations. Employees received all
three doses of the vaccine in the
buttock with a 2.5-cm, 23-gauge nee-
dle. Overall, only 56% (108/194) of the
employees developed antibody to hep-
atitis B surface antigen (anti-HBs)
as measured by the enzyme-linked
immunosorbent assay (Abbott). A
high body weight-height index (a
measure of obesity) was found to be
predictive of a lack of antibody
response.
To date, 41 of the 86 employees who
initially failed to develop anti-HBs
have received two additional doses of
the vaccine in the deltoid using a
2.5-cm, 23-gauge needle. The initial
repeated immunization was con-
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ducted 425 \m=+-\15 days after the comple-
tion of the primary series, and the
second immunization 34 \m=+-\1days lat-
er. Repeated anti-HBs determina¬
tions were done 95 ±1 days after the
last vaccine dose by radioimmunoas-
say (Ausab, Abbott). Overall, 75.6%
(31/41) of the employees had substan¬
tial detectable anti-HBs (ratio of test
sample value to mean negative con¬
trol value [P/N ratio], >10), an addi¬
tional 14.6% (6/41) had low-level
reactivity in the test (P/N ratio, 2.1 to
10), while only 9.8% (4/41) had no
detectable antibody (P/N ratio,
<2.1). Among poor responders (P/N
ratio, <10), seven of ten had a
weight-height index greater than the
sex-adjusted 75th percentile for US
citizens, as compared with only 11 of
31 responders (P/N ratio, >10)
(P=.061, two-tailed Fisher's exact
test).
We conclude that for subjects who
remain seronegative after three doses
of the hepatitis B plasma vaccine
given by buttock injection, two addi¬
tional intramuscular doses into the
deltoid lead to development of anti-
HBs in the vast majority of cases.
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